Regeneron Pharmaceuticals Aktie

993,55USD -0,80USD -0,08%
Regeneron Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 881535 / ISIN: US75886F1075
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 97,97
The Vanguard Group, Inc. 8,19
Fidelity Management & Research Co. LLC 7,89
Vanguard Group, Inc. (Subfiler) 7,86
JPMorgan Investment Management, Inc. 5,46
Capital Research & Management Co. (World Investors) 4,81
State Street Corp. 4,49
Capital Research & Management Co. (World Investors) 4,31
BlackRock Fund Advisors 3,07
Vanguard Total Stock Market ETF 2,99
Capital Research & Management Co. (International Investors) 2,90
American Funds Growth Fund of America 2,83
Vanguard 500 Index Fund 2,49
Fidelity Contrafund 2,46
Geode Capital Management LLC 2,20

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 8 100 9 123 10 368 11 851 13 450
Umsatz pro Mitarbeiter in Mio. EUR 0,97 0,93 1,55 1,03 0,98

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 7 689 9 779 14 015 15 884 19 479
Summe Anlagevermögen 11 804 13 721 21 469 25 365 28 676
Summe Aktiva 14 805 17 163 25 435 29 273 33 131

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 714 2 696 2 700 2 701 2 703
Summe Fremdkapital 3 716 6 138 6 666 6 609 7 158
Summe Eigenkapital 11 090 11 025 18 769 22 664 25 973
Summe Passiva 14 805 17 163 25 435 29 273 33 131

Adresse

777 Old Saw Mill River Road, 10591-6707 Tarrytown
Telefon +1 (914) 847-7000
Internet http://www.regeneron.com

Management

Alan Shuldiner
Vice President-Translational Genetics
Andrew J. Murphy
Executive Vice President-Research
Arthur Frederick Ryan
Independent Director
Benjamin Drosman
SVP-Regulatory Compliance & Global Development
Boaz Hirshberg
SVP-Clinical Sciences General Medicine
Bob McCowan
Chief Information Officer & Senior VP-IT
Bola Akinlade
Senior Vice President-Clinical Development
Bonnie L. Bassler
Independent Director
Christine A. Poon
Lead Independent Director
Christine Childrose
Senior Vice President-Human Resources & Operations
Christopher Robert Fenimore
Chief Financial Officer & Senior VP-Finance
Christos Kyratsous
Senior Vice President-Research
Craig B. Thompson
Director
Daniel P. van Plew
EVP, GM-Industrial Operations & Product Supply
David Paul Schenkein
Director
David Simon
Senior Vice President-Business Operations
George Damis Yancopoulos
Co-Chairman & Co-President
George L. Sing
Independent Director
Gerald Underwood
Senior Vice President-Technical Operations
Huda Y. Zoghbi
Independent Director
Jason Pitofsky
Vice President & Controller
John Calabro
Senior Vice President-Internal Auditor
Johnathan M. Lancaster
Senior Vice President-Global Medical Affairs
Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Joseph L. Goldstein
Independent Director
Kathryn W. Guarini
Independent Director
Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Leonard Brooks
Treasurer & Senior Vice President
Leonard S. Schleifer
Co-Chairman, Co-President & CEO
Lori Morton
Senior Vice President-Research
Lynn Macdonald
Senior Vice President-Research
Marion McCourt
Executive Vice President-Commercial
Mark Hudson
Head-Investor Relations
Mark Volpe
Senior Vice President-Tax
Maya Bermingham
Senior VP-Public Policy & Government Affairs
Melissa Lozner
Chief Compliance Officer & Senior Vice President
Michael S. Brown
Independent Director
N. Anthony Coles
Independent Director
Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Neil Stahl
Executive VP-Research & Development
Nouhad Husseini
Senior VP-Business Development
Patrice Gilooly
Senior VP-Quality Assurance & Operations
Ryan Crowe
Head-Investor Relations
Sally A. Paull
Executive Vice President-Human Resources
Smita Pillai
Chief Diversity, Equity & Inclusion Officer